Sarafloxacin (INN) is a quinolone antibiotic drug,[1][2] which was removed from clinical use by its manufacturer Abbott Laboratories from April 30, 2001.

This systemic antibiotic-related article is a stub.

You can help Wikipedia by expanding it.